lutetium has been researched along with folic acid in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Müller, C; Schibli, R; Struthers, H; Winiger, C; Zhernosekov, K | 1 |
| Haller, S; Leamon, CP; Müller, C; Reber, J | 1 |
| Bernhardt, P; Dorrer, H; Haller, S; Müller, C; Reber, J; Schibli, R; Türler, A; Zhernosekov, K | 1 |
| Bunka, M; Fischer, C; Müller, C; Reber, J; Schibli, R; Türler, A; Zhernosekov, K | 1 |
| Azorín-Vega, E; Ferro-Flores, G; Isaac-Olivé, K; Jiménez-Mancilla, N; Luna-Gutiérrez, M; Mendoza-Nava, H; Ocampo-García, B; Ramírez, FM; Santos-Cuevas, C | 1 |
| Benešová, M; Deberle, LM; Guzik, P; Monné Rodríguez, JM; Müller, C; Ratz, M; Schibli, R | 1 |
| Bernhardt, P; Cohrs, S; Fang, HY; Guzik, P; Müller, C; Schibli, R; Siwowska, K | 1 |
7 other study(ies) available for lutetium and folic acid
| Article | Year |
|---|---|
DOTA conjugate with an albumin-binding entity enables the first folic acid-targeted 177Lu-radionuclide tumor therapy in mice.
Topics: Albumins; Animals; Cell Proliferation; Cell Transformation, Neoplastic; Folic Acid; Heterocyclic Compounds, 1-Ring; Humans; KB Cells; Lutetium; Mice; Molecular Targeted Therapy; Multimodal Imaging; Positron-Emission Tomography; Radioisotopes; Tomography, X-Ray Computed | 2013 |
177Lu-EC0800 combined with the antifolate pemetrexed: preclinical pilot study of folate receptor targeted radionuclide tumor therapy.
Topics: Animals; Cell Line, Tumor; Combined Modality Therapy; Coordination Complexes; Drug Evaluation, Preclinical; Female; Folate Receptors, GPI-Anchored; Folic Acid; Folic Acid Antagonists; Glutamates; Guanine; Humans; KB Cells; Lutetium; Male; Mice; Mice, Nude; Neoplasms, Experimental; Pemetrexed; Pilot Projects; Radioisotopes; Radiopharmaceuticals; Xenograft Model Antitumor Assays | 2013 |
Direct in vitro and in vivo comparison of (161)Tb and (177)Lu using a tumour-targeting folate conjugate.
Topics: Animals; Coordination Complexes; Female; Folic Acid; HeLa Cells; Humans; Lutetium; Mice; Mice, Nude; Neoplasms, Experimental; Radioisotopes; Radiopharmaceuticals; Terbium; Tomography, Emission-Computed, Single-Photon; Xenograft Model Antitumor Assays | 2014 |
Promises of cyclotron-produced 44Sc as a diagnostic match for trivalent β--emitters: in vitro and in vivo study of a 44Sc-DOTA-folate conjugate.
Topics: Animals; Beta Particles; Chelating Agents; Cyclotrons; Feasibility Studies; Female; Folic Acid; Heterocyclic Compounds, 1-Ring; Humans; Isotope Labeling; KB Cells; Lutetium; Mice; Positron-Emission Tomography; Radiochemistry; Radioisotopes; Scandium | 2013 |
Fluorescent, Plasmonic, and Radiotherapeutic Properties of the
Topics: Cell Line, Tumor; Dendrimers; Folic Acid; Gold; Humans; Lutetium; Metal Nanoparticles; Microscopy, Electron, Transmission; Radioisotopes; Radiopharmaceuticals; Spectrometry, Fluorescence | 2017 |
Preclinical evaluation of 5-methyltetrahydrofolate-based radioconjugates-new perspectives for folate receptor-targeted radionuclide therapy.
Topics: Animals; Cell Line, Tumor; Folic Acid; Lutetium; Mice; Radioisotopes; Radiopharmaceuticals; Tetrahydrofolates; Tissue Distribution | 2021 |
Promising potential of [
Topics: Animals; Cell Line, Tumor; Folic Acid; Immunotherapy; Lutetium; Mice; Neoplasms; Radioisotopes; Radiopharmaceuticals | 2021 |